Избранные публикации за 5 лет

1. Shevtsov MA, Nikolaev BP, Ryzhov VA, Yakovleva LY, Dobrodumov AV, Marchenko YY, Margulis BA, Pitkin E, Mikhrina AL, Guzhova IV, Multhoff G. Detection of experimental myocardium infarction in rats by MRI using heat shock protein 70 conjugated superparamagnetic iron oxidenanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine, 2016, 12: 611–621. IF: 6,5; Q1

2. Meshalkina DA, Shevtsov MA, Dobrodumov AV, Komarova EY, Voronkina IV, Lazarev VF, Margulis BA, Guzhova IV. Knock-down of Hdj2/DNAJA1 co-chaperone results in anunexpected burst of tumorigenicity of C6 glioblastoma cells. Oncotarget. 2016; 7:22050–63. IF: 5,167, Q1

3. Mikhaylova ER, Lazarev VF, Nikotina AD, Margulis BA, Guzhova IV. Glyceraldehyde 3‑phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease. J Neurochem. 2016;
136(5):1052–63. IF: 4,87; Q1

4. Abkin SV, Ostroumova OS, Komarova EY, Meshalkina DA, Shevtsov MA, Margulis BA, Guzhova IV. Phloretin increases the anti-tumor efficacy of intratumorally delivered heat-shock protein 70 kDa (HSP70) in a murine model of melanoma. Cancer Immunol Immunother. 2016; 65(1): 83–92. IF: 4,9; Q2

5. Lazarev VF, Sverchinsky DV, Mikhaylova ER, Semenyuk PI, Komarova EY, Niskanen SA, Nikotina AD, Burakov AV, Kartsev VG, Guzhova IV, Margulis BA. 2018. Sensitizing tumor cells to conventional drugs: HSP70 chaperone inhibitors, their selection and application in cancer models. Cell Death Dis. 9:41. IF: 5,959. Q1

6. Ekimova IV, Plaksina DV, Pastukhov YF, Lapshina KV, Lazarev VF, Mikhaylova ER, Polonik SG, Pani B, Margulis BA, Guzhova IV, Nudler E. 2018. New HSF1 inducer as a therapeutic agent in a rodent model of Parkinson’s disease. Exp Neurol. 306:199–208.
IF: 4,83, Q1

7. Nikotina AD, Koludarova L, Komarova EY, Mikhaylova ER, Aksenov ND, Suezov R, Kartzev VG, Margulis BA, Guzhova IV. 2018. Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells. Oncotarget.
9(43):27268–27279. IF: 4,768. Q1 (Scopus)

8. Lazarev VF, Guzhova IV, Margulis BA. Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target. Pharmaceutics. 2020; 12: pii: E416. IF: 4,773 Q1

9. Dutysheva EA, Mikeladze MA, Trestsova MA, Aksenov ND, Utepova IA, Mikhaylova
ER, Suezov RV, Charushin VN, Chupakhin ON, Guzhova IV, Margulis BA, Lazarev VF.
Pyrrolylquinoxaline-2-One Derivative as a Potent Therapeutic Factor for BrainTrauma Rehabilitation. Pharmaceutics. 2020;12: pii: E414. IF 4,773, Q1

10. Margulis B, Tsimokha A, Zubova S, Guzhova I. Molecular chaperones and proteolytic machineries regulate protein homeostasis in aging cells. Cells, 2020; 9(5):1308. Q1